Patents by Inventor Flemming S. Nielsen

Flemming S. Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Composition for Oral GLP-1 Administration Comprising a Tablet Core and Immediate Release Coating
    Publication number: 20220062184
    Abstract: The present invention relates to pharmaceutical compositions comprising a tablet core and an immediate release coating, wherein said tablet core comprises a GLP-1 peptide and an absorption enhancer, as well as uses thereof.
    Type: Application
    Filed: November 19, 2021
    Publication date: March 3, 2022
    Inventors: Pernille Nybo, Flemming S. Nielsen, Birgitte Nissen, Per Sauerberg, Rikke B. Skyggebjerg
  • Tablet formulation comprising a GLP-1 peptide and a delivery agent
    Patent number: 11033499
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: June 15, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Oral Dosing of GLP-1 Compounds
    Publication number: 20190216739
    Abstract: The present invention relates to improved uses of GLP-1 peptides in oral therapy.
    Type: Application
    Filed: March 22, 2019
    Publication date: July 18, 2019
    Inventors: Flemming S. Nielsen, Per Sauerberg
  • Oral dosing of GLP-1 compounds
    Patent number: 10278923
    Abstract: The present invention relates to improved uses of GLP-1 peptides in oral therapy.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: May 7, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Flemming S. Nielsen, Per Sauerberg
  • Tablets comprising GLP-1 agonist and enteric coating
    Patent number: 10265384
    Abstract: The present invention relates to solid pharmaceutical compositions for oral administration comprising a GLP-1 agonist, an absorption enhancer which is a salt of medium-chain fatty acid, and an enteric coating as well as uses thereof.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: April 23, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Birgitte Nissen, Flemming S. Nielsen, Patrick W. Garibay
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL) AMINO) CAPRYLIC ACID
    Publication number: 20180360918
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: August 30, 2018
    Publication date: December 20, 2018
    Inventors: Per Sauerberg, Simon Bjerregaard Jensen, Flemming S. Nielsen
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Patent number: 10086047
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: October 2, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming S. Nielsen
  • Pharmaceutical Composition for Oral GLP-1 Administration Comprising a Tablet Core and Immediate Release Coating
    Publication number: 20180263915
    Abstract: The present invention relates to pharmaceutical compositions comprising a tablet core and an immediate release coating, wherein said tablet core comprises a GLP-1 peptide and an absorption enhancer, as well as uses thereof.
    Type: Application
    Filed: January 28, 2016
    Publication date: September 20, 2018
    Inventors: Pernille Nybo, Flemming S. Nielsen, Birgitte Nissen, Per Sauerberg, Rikke B. Skyggebjerg
  • TABLET FORMULATION COMPRISING SEMAGLUTIDE AND A DELIVERY AGENT
    Publication number: 20180235888
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Application
    Filed: April 20, 2018
    Publication date: August 23, 2018
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Tablet formulation comprising semaglutide and a delivery agent
    Patent number: 9993430
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: June 12, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Tablets Comprising GLP-1 Agonist and Enteric Coating
    Publication number: 20180000903
    Abstract: The present invention relates to solid pharmaceutical compositions for oral administration comprising a GLP-1 agonist, an absorption enhancer which is a salt of medium-chain fatty acid, and an enteric coating as well as uses thereof.
    Type: Application
    Filed: January 28, 2016
    Publication date: January 4, 2018
    Inventors: Birgitte Nissen, Flemming S. Nielsen, Patrick W. Garibay
  • Oral Dosing of GLP-1 Compounds
    Publication number: 20170312225
    Abstract: The present invention relates to improved uses of GLP-1 peptides in oral therapy.
    Type: Application
    Filed: July 17, 2017
    Publication date: November 2, 2017
    Inventors: Flemming S. Nielsen, Per Sauerberg
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20160151462
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: February 9, 2016
    Publication date: June 2, 2016
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming S. Nielsen
  • Oral Dosing of GLP-1 Compounds
    Publication number: 20160067184
    Abstract: The present invention relates to improved uses of GLP-1 peptides in oral therapy.
    Type: Application
    Filed: May 2, 2014
    Publication date: March 10, 2016
    Inventors: Flemming S. Nielsen, Per Sauerberg
  • TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT
    Publication number: 20150150811
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Application
    Filed: June 19, 2013
    Publication date: June 4, 2015
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Long-acting gastrin derivatives
    Patent number: 9040660
    Abstract: The present invention relates to gastrin derivatives comprising gastrin or an analogue or fragment thereof and a derivatisation group and therapeutic use thereof.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: May 26, 2015
    Assignee: Novo Nordisk A/S
    Inventors: Jacob Kofoed, Carsten Engaard Stidsen, Frantisek Hubalek, Flemming S. Nielsen, Henning Thoegersen, Johannes Fels, Rikke Bjerring Andersen, Janos Tibor Kodra
  • Long-Acting Gastrin Derivatives
    Publication number: 20130059781
    Abstract: The present invention relates to gastrin derivatives comprising gastrin or an analogue or fragment thereof and a derivatisation group and therapeutic use thereof.
    Type: Application
    Filed: April 19, 2011
    Publication date: March 7, 2013
    Applicant: NOVO NORDISK A/S
    Inventors: Jacob Kofoed, Carsten Engaard Stidsen, Frantisek Hubalek, Flemming S. Nielsen, Henning Thoegersen, Johannes Fels, Rikke Bjerring Andersen, Janos Tibor Kodra
  • Method for the manufacturing of fuel briquettes
    Patent number: 4372749
    Abstract: A method for manufacturing fuel briquettes from selected components of garbage which are comminuted and combined with coal dust. The mixture of comminuted garbage and coal dust is compressed in a press so as to form a solid body. The proportion of coal dust in the mixture is advantageously adjusted in response to the amount of power which is drawn by a motor which drives the press. In one embodiment, the weight of the coal dust forms at least 20% of the weight of the briquette. The press may be provided with pressing wheels which may be used to comminute the refuse.
    Type: Grant
    Filed: January 23, 1980
    Date of Patent: February 8, 1983
    Inventor: Flemming S. Nielsen